Petrofac LtdShs Aktie 2288748 / GB00B0H2K534
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Historisch | Analysen | |||||
|
23.10.2025 10:00:20
|
Petrofac Limited: RESTRUCTURING UPDATE
|
Petrofac Limited ( PFC)
23 October 2025
RESTRUCTURING UPDATE
Further to its announcement on 21 October, Petrofac confirms it has received notification from TenneT terminating its scope of work on the 2GW programme with immediate effect. Having carefully assessed the impact of TenneT’s decision, the Board has determined that the Restructuring, which had last week reached an advanced stage, is no longer deliverable in its current form. The Group is in close and constant dialogue with its key creditors and other stakeholders as it actively pursues alternative options for the Group. In the meantime, Petrofac remains focused on serving its clients and maintaining operational capability and delivery of services across its businesses. Further information will be shared in due course. ENDS For further information contact: Petrofac Limited +44 (0) 207 811 4900
Sophie Reid, Group Director of Communications
Teneo (for Petrofac) +44 (0) 207 353 4200 petrofac@teneo.com
NOTES TO EDITORS
Petrofac
Petrofac is a leading international service provider to the energy industry, with a diverse client portfolio including many of the world's leading energy companies.
Petrofac designs, builds, manages and maintains oil, gas, refining, petrochemicals and renewable energy infrastructure. Our purpose is to enable our clients to meet the world's evolving energy needs. Our four values - driven, agile, respectful and open - are at the heart of everything we do.
Petrofac's core markets are in the Middle East and North Africa (MENA) region and the UK North Sea, where we have built a long and successful track record of safe, reliable and innovative execution, underpinned by a cost effective and local delivery model with a strong focus on in-country value. We operate in several other significant markets, including India, South East Asia and the United States. We have 7,300 employees based across 31 offices globally.
Petrofac is listed on the London Stock Exchange (symbol: PFC) trading in Petrofac shares is currently suspended pending publication of the Groups Full Year 2024 Audited Accounts.
For additional information, please refer to the Petrofac website at www.petrofac.com
Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement. |
| ISIN: | GB00B0H2K534 |
| Category Code: | MSCU |
| TIDM: | PFC |
| LEI Code: | 2138004624W8CKCSJ177 |
| OAM Categories: | 3.1. Additional regulated information required to be disclosed under the laws of a Member State |
| Sequence No.: | 406018 |
| EQS News ID: | 2217578 |
| End of Announcement | EQS News Service |
|
|
Nachrichten zu Petrofac LtdShs
|
28.10.25 |
Petrofac Limited: CANCELLATION OF LISTING AND TRADING OF PETROFAC ORDINARY SHARES (EQS Group) | |
|
27.10.25 |
Thousands of jobs at risk as Petrofac files for administration (Financial Times) | |
|
27.10.25 |
Thousands of jobs at risk as Petrofac files for administration (Financial Times) | |
|
27.10.25 |
Petrofac Limited: Restructuring Update (EQS Group) | |
|
23.10.25 |
Petrofac Limited: RESTRUCTURING UPDATE (EQS Group) | |
|
21.10.25 |
Petrofac Limited: RESTRUCTURING UPDATE (EQS Group) | |
|
17.10.25 |
Petrofac Limited: RESTRUCTURING UPDATE (EQS Group) | |
|
01.10.25 |
Petrofac Limited: RESTRUCTURING UPDATE (EQS Group) |
Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
SMI geht wenig bewegt ins Wochenende -- DAX schliesslich mit Abgaben -- Wall Street beenden Handel uneins -- Asiens Börsen letztlich schwächerDer heimische Aktienmarkt tendierte am Freitag seitwärts, während der deutsche Aktienmarkt sich abwärts bewegte. An der Wall Street ging es am Freitag in unterschiedliche Richtungen. An den Märkten in Fernost ging es zum Wochenende nach unten.


